Transcription of Fact Sheet: Fludeoxyglucose (18F)
1 sheet : Fludeoxyglucose [ 18 F ] Product SpecificationNameFludeoxyglucose [ 18 F ] IBA, 185 MBq/mL solution for injectionPharmaceutical formSolution for injectionActivity concentration185 MBq/mL at time and date of calibrationRadiochemical purity> 95 %pH and - // Fludeoxyglucose [ 18 F ], sodium chloride and water for injectionsStorageStore in the original package. After first use, store in a refri gerator (2 - 8 C)Expiry12 h from the time of productionIsotopesFluorine-18 Packaging15 mL multi-dose colourless glass vial - type IAvailablityMonday to Friday (Saturday on special request)Calibration10:00 , 2:00 CET (Wednesdays also 5:00 ), same dayDelivery ServiceCyclotron s cooperation partner IBA is the exclusive distributor of our [ 18 F ]FDG and other 18 F - labelled radiopharmaceuticals.
2 IBA is the number one PET-radiopharmaceutical provider [ 18 F ] IBA. 185 MBq/mL solution for : 110 minFludeoxyglucose [ 18 F ] is indicated for use with positron emission to-mography. [ 18 F ]FDG PET is mostly used in the field of oncology. It provides highly accurate diag-nosis and assessment of disease stage and therapeutic are a leading provider of PET-radiopharmaceutitcals and radio-nuclides for the nuclear medicine community. Our expert team en-sures reliable supply of our prod-ucts and the highest possible product quality. Total annual out-put is about 35,000 patient CyCLotRoN VUDe Boelelaan 10811081 HV AmsterdamPostbus 7 1 8021008 EA AmsterdamThe NetherlandsT + 31 (0)20 444 91 23F + 31 (0)20 444 91 28info @ TablePhysical half-life: minHours\ obtain a precalibration number, divide by the decay factor.
3 For a postcalibration number, multiply by the decay InformationBoellaard R et. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):181-200. PMID: DataRad. typeEnergy (keV)Radiation Intensity (%)B+
